Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public advisory - Unauthorized health products from Kausch International Goods may pose serious health risks


OTTAWA, ON, March 1, 2023 /CNW/ - 

Brand: 
Brilliant Skin Essentials 
Solmux

Summary
Images

Brilliant Skin Essentials Brilliant Rejuv Set (CNW Group/Health Canada)

Brilliant Skin Essentials Brilliant Rejuv Topical Cream (CNW Group/Health Canada)

Brilliant Skin Essentials Topical Solution (Toner) (CNW Group/Health Canada)

Brilliant Skin Essentials Rejuvenating Facial Toner (CNW Group/Health Canada)

Carbocisteine Solmux 100mg per 5mL Pediatric Syrup (CNW Group/Health Canada)

Carbocisteine Solmux 200mg per 5mL Pediatric Syrup (CNW Group/Health Canada)

Carbocisteine Solmux Forte 500mg per 5mL Adult Suspension (CNW Group/Health Canada)

Affected products

Product

 

Promoted use

Health risk

Brilliant Skin Essentials Brilliant Rejuv Set

Skin lightening

Labelled to contain hydroquinone and tretinoin.

Brilliant Skin Essentials Brilliant Rejuv Topical Cream

Skin lightening

Labelled to contain hydroquinone and tretinoin.

Brilliant Skin Essentials Topical Solution (Toner)

Skin lightening

Labelled to contain hydroquinone and tretinoin.

Brilliant Skin Essentials Rejuvenating Facial Toner

Skin lightening

Product with similar packaging (previously removed from sale) was tested and found to contain tretinoin.

Solmux Carbocisteine 100mg/5mL Pediatric Syrup

Mucolytic (thins mucus)

Labelled to contain carbocisteine.

Solmux Carbocisteine 200mg/5mL Pediatric Syrup

Mucolytic (thins mucus)

Labelled to contain carbocisteine.

Solmux Carbocisteine Forte 500mg/5mL Adult Suspension

Mucolytic (thins mucus)

Labelled to contain carbocisteine.

 

Issue

Health Canada is warning consumers about unauthorized health products that it removed from sale from Kausch International Goods' online Facebook store and its associated warehouse in Calgary, AB. The unauthorized products were labelled or previously tested and found to contain prescription drugs and may pose serious health risks.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects.

 What you should do
Background

Carbocisteine is a prescription drug that is not approved for use in Canada. It is used in other countries to treat conditions associated with too much mucus in the respiratory tract. Side effects include diarrhea, nausea and heartburn. Serious allergic (e.g., anaphylactic) and skin reactions have been reported with its use. Carbocisteine can disrupt the lining of the stomach and can cause gastrointestinal bleeding in the elderly, those with a history of peptic ulcers, or patients taking medications known to cause gastrointestinal bleeds such as acetylsalicylic acid (ASA) or non-steroidal anti-inflammatory drugs (NSAIDs). The use of carbocisteine by pregnant people is not recommended.

Hydroquinone is a prescription drug when it is greater than a 2% concentration and a natural health product at a concentration of 2% and under. It is used topically (applied to the skin) to lighten areas of darkened skin caused by different conditions (e.g., sun exposure, skin damage, pregnancy, medications or age). It should not be used by people who are allergic to hydroquinone or who are taking medicines that make their skin more sensitive to light. Hydroquinone is not recommended for pregnant or breastfeeding people, or for children. It should be used with caution in those who have previously had cancer. Side effects include skin reactions such as redness, dryness, cracked skin, burning, stinging, peeling, itching, increased sensitivity to sunlight, sunburn, blisters and scarring. It may cause skin discolouration (i.e., blue or black discolouration or white patches or spots) that, in some cases, can be disfiguring. In laboratory animals, it has been associated with cancer after long-term exposure.

Tretinoin in topical format (applied to the skin) is a prescription drug used to treat acne. Topical tretinoin should not be used during pregnancy as it has been associated with birth defects. It should also not be used by those who are breastfeeding or by children under 12 years old, or by individuals who have inflamed or irritated skin, have a previous skin cancer or undiagnosed skin lesions, who are taking medicines that make their skin more sensitive to light, or who have an allergy to tretinoin. Tretinoin may cause pain, irritation, itchiness, redness, or swelling at the site of application. It may damage skin, change skin colour, and increase sensitivity to sunlight or tanning beds, causing sunburns. Using tretinoin in combination with hydroquinone may increase some of the side effects of tretinoin.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 21:15
The National Health IT Collaborative for the Underserved (NHIT), the first and oldest national non-profit focused on equitable access to health technology for underserved communities and communities of color, celebrated its 15th anniversary today...

at 21:00
The "Social Anxiety Disorder (SAD) - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The Social Anxiety Disorder (SAD) market report provides current treatment practices, emerging...

at 20:45
The "Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast" report has been added to  ResearchAndMarkets.com's offering. Technological advancements and strategic partnerships create new opportunities for CGM vendors. The rising...

at 20:40
Researchers at Kanazawa University report in ACS Nano how ultrathin layers of tin disulfide can be used to accelerate the chemical reduction of carbon dioxide - a finding that is highly relevant for our quest towards a carbon-neutral society....

at 20:15
The "Regenerative Medicines: Bone and Joint Applications" report has been added to  ResearchAndMarkets.com's offering. The global market for regenerative medicine for bone and joint applications was valued at $9.6 billion in 2022. By technology, this...

at 20:10
The Canadian Animal Health Institute is thrilled to announce the winners of the inaugural ?Cutest Pets on Parliament Hill Contest'. Parliamentarians, Senators, staffers, and members of the Press Gallery on Parliament Hill, submitted more than 65...



News published on and distributed by: